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Abstract
Background: Digital mental health interventions can be effective for treating mental health problems, but uptake by
consumers and clinicians is not optimal. The lack of an accreditation pathway for digital mental health interventions is
a barrier to their uptake among clinicians and consumers. However, there are a number of factors that may contribute to
whether a digital intervention is suitable for recommendation to the public. The aim of this study was to identify the types of
evidence that would support the accreditation of digital interventions.
Method: An expert workshop was convened, including researcher, clinician, consumer (people with lived experience of a
mental health condition) and policymaker representatives.
Results: Existing methods for assessing the evidence for digital mental health interventions were discussed by the stake-
holders present at the workshop. Empirical evidence from randomised controlled trials was identified as a key component
for evaluating digital interventions. However, information on the safety of users, data security, user ratings, and fidelity to
clinical guidelines, along with data from routine care including adherence, engagement and clinical outcomes, were also
identified as important considerations when evaluating an intervention. There are considerable challenges in weighing the
evidence for a digital mental health intervention.
Conclusions: Empirical evidence should be the cornerstone of any accreditation system to identify appropriate digital mental
health interventions. However, robust accreditation systems should also account for program and user safety, user engage-
ment and experience, and fidelity to clinical treatment guidelines.
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There is extensive evidence that digital mental health
interventions can be effective for treating mental health
problems.1–5 However, uptake by community members
and clinicians for some evidence-based services has
been limited, which may result from a failure of imple-
mentation into practice,1,6 from limitations on the
appropriateness of research evidence,7 or from
market saturation of untested interventions.8,9 Digital
mental health interventions are defined here as online
programs and apps that deliver structured therapy
(based on existing evidence) to the user, in either a
self-guided or clinician-supported format. This defini-
tion excludes therapy delivered live by clinicians using
technology, informational or non-therapeutic pro-
grams, and tools used exclusively by clinicians.
Clinician and consumer barriers to the use of these
interventions include limited awareness of digital
mental health interventions and their appropriateness
for different mental health problems, preference for
face-to-face care, lack of knowledge of the evidence
base supporting their use, poorly integrated delivery
pathways, concerns around the privacy of using these
interventions, a perceived gap between users’ actual
needs and the problems typically addressed by diagnos-
tically driven online interventions, a lack of user input
into the design and delivery of interventions, and a lack
of formal accreditation processes that would feed into
the identification and delivery of appropriate digital
interventions to the public.1,6,10,11
A number of directories or portals of digital mental
health interventions are now available, and may be
employed to support the use of such interventions in
clinical, community or individual settings. Some of
these, such as Beacon12 and Psyberguide13 include an
evaluation of the empirical evidence for each available
intervention, which allows users to identify programs
that have the strongest evidence base for efficacy.
However, there are broader considerations that may
be important in assisting potential users to determine
the most appropriate intervention.14 Accreditation sys-
tems for digital interventions need to account for mul-
tiple factors in identifying interventions that are
appropriate for public use and providing recommenda-
tions to clinicians or consumers.
We report on the outcomes of an expert workshop
that was convened to discuss the challenges in assessing
evidence for digital mental health interventions and
how these issues might feed into systems of accredita-
tion for such interventions. Formal systems of accred-
itation for digital interventions are emerging, such as
the UK Digital Assessment Questionnaire (DAQ)15
and the US Food and Drug Administration’s proce-
dures for approval of digital tools as medical devices.16
However, the workshop was designed to identify the
viewpoints of diverse stakeholders on how different
types of evidence can be integrated into new accredita-
tion systems, without specific reference to these emerg-
ing accreditation systems.
Method
Attendees of the workshop (n¼ 15) were researchers in
digital mental health (n¼ 9, three were also clinicians),
clinicians (n¼ 5), a representative of people with lived
experience of mental health condition (n¼ 1),
Government representatives from the Australian
Department of Health (n¼ 2) and a note-taker.
Although only one consumer representative attended,
specific discussion points around consumer engage-
ment were included in the agenda, with discussion in
this area led by the consumer representative. The 5-h
workshop was conducted as an unmoderated group
discussion in February 2018 to inform the ongoing
development of the Australian Government’s headto-
health portal (https://headtohealth.gov.au), a website
that lists Australian information, resources and services
to support mental health. The Beacon approach for
assessing empirical evidence for web-based therapy
programs, apps and Internet support groups was
described. Beacon is a catalogue describing existing
online health interventions with an evidence rating
based on randomised controlled trials and other empir-
ical designs.12 Loosely following an agreed agenda, lim-
itations to the Beacon methodology were discussed,
along with broader challenges of relying primarily on
evidence from randomised controlled trials (RCTs) for
each digital program or resource to facilitate the selec-
tion of appropriate digital interventions. In addition to
empirical evidence, other important indicators to guide
selection of digital mental health interventions for clini-
cians and consumers were identified. Discussions were
structured around identifying appropriate evidence for
three types of interventions: online programs, apps,
and Internet support groups (which are outside the
scope of the current paper).
Results
Existing approaches to rating digital health
interventions
Existing techniques for assessing digital mental health
interventions were identified by workshop participants,
as current approaches may provide more efficient path-
ways to developing a rigorous evaluation or accredita-
tion framework. Some of these approaches focus only
on empirical evidence, while others account for user
experience, security of data systems and/or alignment
with clinical treatment guidelines.
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Relevant approaches to evaluating digital interven-
tions identified in the workshop include:
• Beacon (https://beacon.anu.edu.au/): Australian-
based directory of internationally available digital
health programs (web-based, mobile apps) with rat-
ings based on peer-reviewed scientific evidence;
• Psyberguide (https://psyberguide.org/): directory of
mental health apps with ratings on scientific evi-
dence, user experience, and clarity of the privacy
policy, based in the United States;
• Mobile Application Ratings Scale:17 a tool to rate
apps focusing primarily on usability and engage-
ment, but also including an expert rating of content.
The scale has potential for adaptation to
rate websites;
• NICE Guidelines (https://www.nice.org.uk/guid
ance): a framework for identifying which therapeutic
strategies are likely to be consistent with treat-
ment guidelines.
Additional resources that include listings of digital
interventions include:
• headtohealth (https://headtohealth.gov.au): recently
developed Australian Government portal for digital
and other mental health services, which does not
provide an evaluation;
• NHS apps database (https://apps.beta.nhs.uk/):
directory of apps, with inclusion based on multiple
inputs including a technical assessment of data secu-
rity, DAQ assessments and NICE guidelines, based
in United Kingdom;
• National Registry of Evidence-based Programs and
Practices (https://nrepp.samhsa.gov): US listing of
evidence-based programs, which includes some dig-
ital programs (listings are provider-driven and must
be accredited), based in United States.
The role and limitations of empirical evidence
The workshop discussion primarily centred on the roles
of empirical evidence and other forms of evidence, and
how different forms of evidence might be used to
inform accreditation processes. There was consensus
on the majority of discussion points, except where
noted below. Disagreements in the workshop were
not confined to specific stakeholder groups, but pri-
marily occurred within the researcher (or researcher-
clinician) group.
The attendees of the workshop noted the impor-
tance for clinicians and community users to have
access to an updated database of available online inter-
ventions, with the scientific evidence for each interven-
tion described and rated in an accessible way.
Such databases provide clinicians and consumers with
up-to-date information to guide their decisions about
interventions that are most likely to be effective for
them and suited to their needs. The Beacon directory
assesses empirical evidence for digital mental health
interventions largely on the basis of the number of
RCTs with a positive outcome. Based on this system,
more positive RCTs result in a higher evidence rating.
However, RCTs for specific programs are not the only
form of evidence, and there are a number of challenges
and nuances that were discussed when assessing empir-
ical evidence.
RCTs are highly variable and may not be appropri-
ate in some conditions.18 Discussion in the workshop
noted that the quality of RCTs can vary, and depends
on factors including sample size, randomisation
method, blinding, and type of comparison/control con-
dition. The quality of an RCT may impact on the
results obtained, raising questions as to how to account
for low-quality studies when assessing the evidence
base. RCTs can be conducted in a range of settings.
For example, a prevention trial of a self-guided pro-
gram in schools is likely to have different expectations
and outcomes compared to a treatment trial of a
clinician-guided program delivered in a clinical setting.
The type of program (self-guided versus clinician
guided), the type of participants (e.g. healthy popula-
tion versus severe clinical population, or specific sub-
groups defined by age, gender, ethnicity, etc.), the
delivery setting (e.g. online, clinic, school, community)
and the mental health target (e.g. depression, anxiety,
substance use) are all likely to play a role in the out-
comes of a trial. Moreover, as interventions are rede-
signed, turned into apps, become outdated or are used
in ways that differ markedly from trial conditions, it is
unclear the extent to which existing evidence remains
valid. It was also noted in the workshop that RCTs
conducted by an organisation independent of the devel-
opers of the intervention may be viewed by some as
more rigorous than RCTs conducted by the developers.
Attendees of the workshop were of the opinion that,
following evidence from RCTs, large-scale effectiveness
trials using data obtained from routine care provide
useful information to inform public policy but are
rarely conducted. There was also a consensus that evi-
dence needed for apps was equivalent to that for
online programs.
In addition to empirical evidence for effectiveness,
adherence to and engagement with a digital interven-
tion may be important considerations. Poor adherence
may indicate an intervention is not engaging, and trials
with high drop-out may have biases in the estimation of
effects. Interventions that are shown to be effective in
an RCT may still have suboptimal user engagement.19
However, it remains imperative that the designers of
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interventions aim to optimise the user experience, as
this is vital for effective, safe and engaging delivery.
To this end, additional data such as adherence rates
or consumer ratings may provide a clearer picture of
how engaging a program is likely to be. It was noted
that adherence is a complex outcome, and that early
drop-out from an intervention may indicate a partici-
pant has had a positive response and hence, discontin-
ued program use. Furthermore, trials with poor
adherence or small sample sizes are less likely to
show a positive effect, as the power to find a difference
in effect is restricted. However, it was also noted that
trials with poor adherence may reflect a poorly
designed and ineffective intervention, emphasising the
importance of monitoring outcomes from routine care.
Safety was discussed extensively during the work-
shop, and is a critical element for the identification of
digital interventions that are appropriate for public use.
The concept of safety covers both user safety (i.e. assur-
ances that a digital intervention will not cause harm or
increase the likelihood of deterioration) and digital
safety (i.e. privacy and data security). It was noted
that few trials report rates of deterioration, although
interventions that are shown to be effective typically
have fewer users with deterioration than in control
conditions.20 Interventions that are delivered within a
service setting may have more extensive clinical data on
user safety but may not have a comparator (i.e. a con-
trol condition) to enable benchmarking of the expected
rates of deterioration without active intervention. It
may be possible to assess data privacy and security
by seeking information from providers about their pol-
icies, platforms and standards for security, and main-
taining user privacy. However, independently verifying
these claims remains challenging.21,22
There are other types of data that may indicate that
a digital intervention is likely to be efficacious or effec-
tive, beyond RCTs. Discussions focused on two forms
of data. Firstly, clinical service data from routine care
(or relatedly, other types of empirical studies such as
open trials) can be used to support the effectiveness and
safety of an intervention. Programs that are delivered
to the community as a clinical service may have con-
siderable and detailed data on how specific types of
users respond to programs over time.23 Such services
can continuously provide data on usage and clinical
outcomes, can monitor user safety and can be used to
identify appropriate clinical dosage. Such data are
essential for determining the actual clinical benefits
and risks when deployed in routine care, information
which is essential for funders and planners. Secondly,
fidelity to clinical guidelines may provide further evi-
dence that an intervention is likely to be effective.
Ensuring that program content is consistent with clin-
ical treatment guidelines and does not include
unsupported treatment strategies is one way to provide
some reassurance that an intervention is likely to be
useful and safe for users. Indeed, a minority of attend-
ees (reflecting some of the researchers and clinicians
providing Internet-based services) viewed fidelity to
existing evidence-based programs as sufficient for meet-
ing minimum standards for accreditation, much as
other new (non-digital) clinical services that conform
to clinical guidelines are not expected to undergo
RCTs. Fidelity to clinical guidelines or evidence-
based practice could be assessed using an expert clinical
review of the intervention, for example.9 However, it
was noted that a program may be entirely consistent
with clinical guidelines but have poor outcomes, poten-
tially due to low user engagement (e.g. if a program is
too text-heavy).
Discussion
The outcomes of the workshop with expert stakehold-
ers, including clinician and consumer representatives,
indicated a number of challenges for the development
of accreditation systems that provide information
about the suitability of Internet interventions based
on multiple sources of evidence. There was consider-
able agreement among the attendees on issues such as
the need for high-quality evidence of effectiveness, dig-
ital safety and user safety, along with demonstration
that an intervention is engaging for its intended audi-
ence. There was also agreement that fidelity to clinical
guidelines and data from routine service delivery pro-
vide important indicators of effectiveness and safety,
although there was no consensus on whether such
data alone would be sufficient for an accreditation
system. There was also no consensus on the role of
RCTs. Trials were seen by all attendees as providing
high-quality evidence but the challenges of conducting
timely trials that reflect real-world use of Internet inter-
ventions may limit their applicability and feasibility,
necessitating the use of other forms of evidence.
A majority of attendees viewed programs that do not
have RCT data as problematic, as evaluations without
a control group may reflect non-specific effects of an
intervention or a natural course of improving symp-
toms. Overall, it was not possible to form a consensus
on the best balance between multiple forms of
evidence – this balance would need to be considered
within the context of how an accreditation system is
designed and delivered.
Existing directory services such as Beacon that
assess empirical evidence using objective metrics (e.g.
number of positive RCTs) are advantageous due to
their transparency, simplicity, objectivity and reliance
on high-quality evidence. However, this approach may
not consider aspects of trial quality and other forms of
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empirical evidence, which may disadvantage interven-
tions with poor adherence or those evaluated using
small samples, or ones with evidence using non-RCT
methodology. Reliance on data from RCTs may also
be insufficient to demonstrate their uptake, clinical
benefits and risks when implemented at scale as a clin-
ical service that is available to the public, an important
consideration when developing accreditation systems.
There are other important factors to account for in
assessing whether an intervention is likely to be effec-
tive and safe. Some interventions may be effective only
for a subgroup of the population or when used in par-
ticular ways. Consumer ratings and adherence rates
may provide a guide to how engaging an intervention
is likely to be, an important consideration in recom-
mending interventions. Many of these factors are
being incorporated into emerging accreditation systems
such as the DAQ. However, further consideration of
the roles of different forms of evidence in the develop-
ment of recommendations to consumers and clinicians
is warranted, taking into account the diverse view-
points of developers and end users. In particular, ques-
tions remain around the feasibility, sustainability and
impact of accreditation processes and their inclusion of
consumer and clinician evaluations of interventions.
Developing a feasible, sustainable and impactful
accreditation or certification process
In developing an accreditation system for digital inter-
ventions, there are a number of factors that are likely to
be important to ensure that the system provides useful
recommendations to clinicians and consumers. At a
minimum, standards should account for some level of
empirical evidence that an intervention is effective and
safe for users, along with evidence for data security,
including protections for the privacy of users and trans-
parency around security policies. Standards for report-
ing program content24 and e-health trials,25 including
comparisons of deterioration rates and reporting of
adverse events, would assist in identifying programs
that are likely to be safe for users.
In addition, use of clinical service data26 and fidelity
to evidence-based practise or clinical treatment guide-
lines27 are indicators that should be routinely reported.
Such data will indicate whether a program is likely to
be appropriate for use in the community and is deliv-
ering what it purports to deliver (e.g. cognitive behav-
iour therapy for depression). Clinical service data can
establish ongoing positive impact and low deterioration
rates, which may be used as a requirement for ongoing
accreditation of a publicly available service. Expert
clinical judgement may provide evidence for fidelity
to clinical guidelines or existing treatment protocols,
although evaluation of fidelity requires an objective
rating framework to be developed and evaluated24
and does not guarantee effectiveness, safety or
acceptability.
User ratings from clinicians and consumers within a
curated repository of digital mental health interven-
tions may also be a valuable metric to assist users to
determine whether a digital intervention might be
appropriate and engaging. There are also many chal-
lenges of implementing a user rating system, including
subjectivity of ratings, scope to ‘game’ the system, need
for moderation, and the resources required to set up
and maintain a robust and user-friendly rating system.
It should also be noted that user star ratings within
general app stores have been shown to have limited
correlation with measures of the clinical quality of
apps.28 Establishing independent panels of clinician
and consumer users to provide a consistent rating pro-
cess may overcome some of these challenges. An effi-
cacious intervention may be ineffective if it is not
designed around the needs of the user.
Indicators for the multiple attributes that may be
used to identify an appropriate digital intervention
are likely to be independent (e.g. user engagement
may not always be consistent with effectiveness).
Therefore, it may be challenging to develop overall
benchmarks to identify whether a program should be
recommended by an accreditation process. Reporting
of individual indicators may be preferable and allow
users to focus on the areas that are most important
to them, with potential for an accrediting agency to
establish minimum standards for each attribute.
Accreditation procedures may require flexibility to
assess the total body of evidence available for a digital
intervention and present this evidence in a way that
meets the needs of both clinicians and consumers.
This information should include the contexts and spe-
cific outcomes where the digital intervention has docu-
mented impact.
Currently, digital interventions operate along a con-
tinuum of regulatory requirements, from therapist-
guided interventions that typically must comply with
practitioner regulations, to self-guided apps that typi-
cally have no such requirements. Apps are often devel-
oped by laypeople with no oversight or accountability,
or by software companies with limited expertise in
mental health or research methodology. Information
on the attributes important to accreditation may be
collected in several ways. The onus could be placed
on providers to demonstrate that they meet minimal
criteria for efficacy, effectiveness when deployed
within the targeted population or relevant service set-
ting, safety and user engagement, or an independent
panel could collect this information. There may be
risks in a self-report model, such as a lack of indepen-
dence and limited expertise or resourcing.
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Alternatively, external peer review models or a combi-
nation of methods could be used, although the volume
of interventions available is likely to require limits on
the scope of external reviews. The choice of an accred-
itation model may require choosing an appropriate
business model to ensure that the process is dynamic,
so that listings remain up to date, followed by building
public awareness and trust in the system. Updating the
evidence base as programs age will remain a challenge,
although linking evidence updates to an accreditation
process may ensure greater accountability. There also
remains a need for sufficient expertise, training and
standard processes to rigorously measure each compo-
nent of an accreditation system.
Limitations
A limitation of this paper is that other types of digital
support interventions, such as Internet support groups
and chat-based therapy, may be more difficult to incor-
porate into an accreditation process, as it may be chal-
lenging to assess clinical outcomes in these settings and
standardised delivery cannot be guaranteed. The mar-
keting and promotion of directories or accreditation
systems is an additional challenge, as existing
evidence-based portals compete with app stores,
search engines, and other established and well-funded
sources of information that neglect quality indicators.
The inclusion of a variety of stakeholders in the work-
shop was a strength, although it was not feasible to
include a wide selection of consumers or carers, over-
seas experts, or other experts such as information tech-
nology experts, who may have divergent viewpoints.
Further investigation of how consumers, carers and
clinicians weigh different forms of evidence
is warranted.
Conclusions
Empirical evidence for effectiveness should be the cor-
nerstone of any accreditation or directory system that
identifies appropriate digital mental health interven-
tions. Although RCTs remain the strongest evidence
that a program is efficacious, they may not provide
evidence of effectiveness. Furthermore, there are limi-
tations to the use of RCTs7,18 and limitations in the
application of trial evidence to the delivery of interven-
tions as a clinical service. Ideally, RCT evidence should
also be supported by evidence for effectiveness from
large-scale pragmatic effectiveness trials in the relevant
population or clinical settings, which enable regular
reporting of outcomes that are relevant to users, clini-
cal services and funding organisations. Robust accred-
itation systems should also account for program and
user safety, user engagement and experience, and
fidelity to clinical treatment guidelines. The key out-
comes and indicators that go into any evaluation of
existing digital interventions should be transparent,
systematic and objective.
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